Loncar China BioPharma ETF (CHNA) ETF Holdings & Portfolio Analysis - Complete Fund Breakdown - Stocknear

Loncar China BioPharma ET...

NASDAQ: CHNA · Real-Time Price · USD
13.53
-0.01 (-0.07%)
At close: Oct 17, 2023, 9:51 PM

CHNA Holdings List

As of Apr 17, 2023
The Loncar China BioPharma ETF is an equity ETF with a total of 9 individual holdings. The top holdings are Legend Biotech at 2.06%, Zai Lab at 1.99%, BeiGene, at 1.89%, I-Mab at 1.65%, and HUTCHMED (China) at 1.29%.
9
12.50%
Equity
9.97M
n/a
0.7900%

Sector Allocation

Rank Symbol Name Price % Change Shares % Weight
1 LEGN Legend Biotech ...
33.47
-2.28% 9.65K 2.06%
2 ZLAB Zai Lab Limited
28.40
-9.81% 2.18K 1.99%
3 BGNE BeiGene, Ltd.
184.71
+0.49% 1.04K 1.89%
4 IMAB I-Mab
4.18
-9.13% 4.26K 1.65%
5 HCM HUTCHMED (China...
15.71
-2.12% 7.87K 1.29%
6 BNR Burning Rock Bi...
8.87
-6.43% 8.45K 1.29%
7 GTH Genetron Holdin...
4.03
+0.12% 9.63K 1.06%
8 GRCL Gracell Biotech...
10.25
+0.05% 9.46K 0.77%
9 CASI CASI Pharmaceut...
2.36
+0.85% 54.83K 0.50%